Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1978-07-12
1980-12-09
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 424 12, G01N 3316, B01J 122, G21H 502
Patent
active
042384710
ABSTRACT:
Automated assay for qualitative determination of thyroid hormone binding capacity of a serum sample in which serum and T.sub.3 tracer are caused to flow through a chamber containing a T.sub.3 binder supported on a solid support. The amount of T.sub.3 tracer which passes through the chamber, and the amount of T.sub.3 tracer bound to the binder in the chamber are determined to thereby determine the percent of bound T.sub.3 tracer. Such percent is then compared with the percent of T.sub.3 tracer bound in a referenced sample to qualitatively determine the T.sub.3 binding capacity of the serum sample.
REFERENCES:
patent: 3896217 (1975-07-01), Johnson
patent: 3941564 (1976-03-01), Fader et al.
patent: 4039652 (1977-08-01), Adams et al.
patent: 4108976 (1978-08-01), Reese
patent: 4110076 (1978-08-01), Margher et al.
patent: 4125375 (1978-11-01), Hunter
patent: 4128628 (1978-12-01), Brooker et al.
Johnson Lavell R.
Reese Max G.
Becton Dickinson and Company
Marn Louis E.
Nucker Christine M.
Olstein Elliot M.
Padgett Benjamin R.
LandOfFree
Assay for thyroid hormone binding capacity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Assay for thyroid hormone binding capacity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Assay for thyroid hormone binding capacity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2280368